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Aim: The prevalence of obesity is a major risk factor for cardiovascular and metabolic 
diseases including impaired skeletal muscle regeneration. Since skeletal muscle 
regenerative capacity is regulated by satellite cells, we aimed to investigate whether 
a high-fat diet impairs satellite cell function and whether this is linked to fatty acid 
uptake via CD36. We also aimed to determine whether loss of CD36 impacts on 
muscle redox homeostasis and skeletal muscle regenerative capacity.
Methods: We studied the impact of a high-fat diet and CD36 deficiency on murine 
skeletal muscle morphology, redox homeostasis, satellite cell function, bioenergetics 
and lipid accumulation in the liver. We also determined the effect of CD36 deficiency 
on skeletal muscle regeneration.
Results: High-fat diet increased body weight, intramuscular lipid accumulation and 
oxidative stress in wild-type mice that were significantly mitigated in CD36-deficient 
mice. High-fat diet and CD36 deficiency independently attenuated satellite cell function 
on single fibres and myogenic capacity on primary satellite cells. CD36-deficiency 
resulted in delayed skeletal muscle regeneration following acute injury with 
cardiotoxin. CD36-deficient and wild-type primary satellite cells had distinct 
bioenergetic profiles in response to palmitate. High-fat diet induced hepatic steatosis 
in both genotypes that was more pronounced in the CD36 deficient mice.
Conclusion: This study demonstrates that CD36 deficiency protects against diet-
induced obesity, intramuscular lipid deposition and oxidative stress but results in 
impaired muscle satellite cell function, delayed muscle regeneration and hepatic 
steatosis. CD36 is a key mediator of fatty acid uptake in skeletal muscle, linking obesity 
with satellite cell function and muscle regeneration.  
Key words: high-fat diet, obesity, CD36 deficiency, satellite cells, oxidative stress, 
regeneration
































































Skeletal muscle stem cells, also called satellite cells, are the major source of newly 
forming myoblasts and of crucial importance for postnatal muscle growth, 
maintenance, regeneration and hypertrophy 1 2 3. Satellite cells are located between 
the basal lamina and the sarcolemma, where they reside in a mitotically quiescent 
state in the healthy adult skeletal muscle 1,4. Upon stimulation by muscle maintenance 
pathways or injury, satellite cells exit their quiescent state and enter the cell cycle. The 
vast majority will then continue to proliferate and differentiate towards the myogenic 
lineage, forming new myoblasts, whereas a small number of satellite cells return to a 
quiescent state, replenishing the skeletal muscle stem cell pool 1 2 3. Satellite cell 
function is a complex and tightly regulated process with particular relevance for muscle 
biology and metabolism. Impaired satellite cell function has been associated with a 
variety of muscle diseases such as Duchenne muscular dystrophy and age-related 
sarcopenia 5,6. 
Additionally, accumulating evidence shows that skeletal muscle function and 
regeneration is compromised in obesity and type 2 diabetes 7-12. Perturbed muscle 
metabolic capacity leads to insulin resistance, increased fatty acid uptake and 
intramuscular triacylglycerol accumulation in skeletal muscle of obese and diabetic 
individuals 13-16. CD36, as one of the major fatty acid transporters in skeletal muscle 
17, has been shown to be upregulated under high-fat diet conditions 18,19 further 
facilitating the transport and ectopic accumulation of lipids. Translocation and elevated 
expression of CD36 in various tissues such as cardiac tissue 20-22 and skeletal muscle 
23 result in lipid overload and lipotoxicity 24 accelerating the development of metabolic 
disorders, collectively described as the metabolic syndrome. Although previous 
studies have already revealed several unfavourable changes in the obese condition, 































































such as increased susceptibility to muscle damage 25,26, decline in general muscle 
health and impaired regenerative capacity 10,27, the underlying cellular and metabolic 
changes are still poorly understood. 
Given the importance of the skeletal muscle function and metabolism in the context of 
obesity and diabetes, it is paramount to understand the mechanism linking obesity and 
impaired muscle health. Since skeletal muscle regenerative capacity is regulated by 
the satellite cell function, we aimed to investigate the effects of diet-induced obesity 
on satellite cell function. We hypothesised that obese mice would display impaired 
satellite cell function due to lipid overload of skeletal muscle tissue. Specifically, we 
sought to examine whether high-fat diet (HF) impaired satellite cell function that can 
be linked to fatty acid uptake via CD36. Furthermore, we aimed to determine whether 
loss of CD36 impacts on muscle redox homeostasis and skeletal muscle regenerative 
capacity.
































































CD36 knockout mice are protected from weight gain in response to high-fat diet. 
To determine whether loss of CD36 protects from weight gain, wild-type (WT) and 
CD36 knockout (KO) mice were fed a HF diet (HF) or a normal diet (ND) for 13 weeks 
(Figure 1A). Body weight was recorded weekly, including the final body weight at 
week 13 (Figure 1B-D). HF diet gradually increased body weight in WT mice starting 
from week 4 which was more pronounced by week 13, compared to mice fed a ND 
(Figure 1C, D). WT mice displayed an increased bodyweight by 37% after 13 weeks 
of HF diet and developed obesity compared to the WT littermates maintained on a 
standard laboratory chow (ND). Conversely, CD36 KO mice fed a HF diet showed 
decreased body weight gain compared to the WT HF group (i.e. 14 versus 37% 
respectively; interaction p=0.009) and no significant difference when compared to WT 
ND (1%) or CD36 KO ND (14%) mice (Figure 1C, D). We further found the weights of 
the soleus (Sol) and biceps brachii (BB) muscles to be increased by HF diet in the WT, 
but not the KO animals. Most strikingly, we found the white adipose tissue (WAT) 
weight to be significantly higher in WT HF diet animals (2-fold; significant interaction 
p=0.0012) when compared to HF diet CD36 KO mice (Supplementary Figure 1A-F). 
These findings indicate that CD36-deficient mice are protected from HF diet-induced 
obesity. 
CD36 KO mice show reduced lipid accumulation in skeletal muscle in response 
to high-fat diet. Intramuscular assessment of neutral lipid content was measured by 
BODIPY staining. The HF diet induced significantly higher lipid accumulation in the 
tibialis anterior (TA) muscle in WT mice (p<0.001; Figure 2A, B). In contrast, HF diet 
failed to induce a significant increase in BODIPY staining in CD36 KO mice. These 
findings were confirmed by quantifying intramuscular triacylglycerol (TG) accumulation 































































by gas chromatography. Total phospholipid content was significantly lower in CD36 
KO mice independent of diet (Figure 2C). Given that HF diet is often associated with 
morphological changes of the skeletal muscle 28, we investigated muscle specific 
changes of fibre type composition and size. Immunohistochemistry revealed a 
significant reduction in number and size of type IIB fibres of the extensor digitorum 
longus (EDL) muscle in WT HF versus WT ND. No significant changes were found in 
soleus with regard to genotype or diet (Supplementary Figure 2). We next examined 
the expression of genes involved in fatty acid uptake and utilization as well as cross-
talk between adipose tissue and skeletal muscle using quantitative reverse-
transcription polymerase chain reaction (qRT-PCR). Relative mRNA expression of 
Fibronectin type III domain-containing protein 5 (Fndc5) and Interleukin 15 (IL-15) 
revealed a significant increase in CD36 KO HF diet mice compared to WT ND and HF 
mice. Furthermore, mRNA levels of Fatty acid binding protein 3 (Fabp3) and Carnitine 
palmitoyltransferase I (Cpt1) were significantly increased in CD36 KO mice (Cpt1) or 
both in WT and CD36 KO mice on a HF diet (Fabp3) when compared to control 
littermates (Figure 2D).
Skeletal muscle from CD36 KO mice is protected from high-fat diet-induced 
oxidative stress. Recent evidence indicates a direct link between the production of 
diet-induced reactive oxygen species (ROS) and levels of oxidative protein 
modifications such as 4-hydroxynonenal (4-HNE) and 3-nitrotyrosine (3NT) adducts 
that are involved in the development of metabolic disorders 29-32. Loss of CD36 is 
known to attenuate ROS production, alleviating oxidative stress 33,34. Therefore, we 
sought to determine the impact of CD36 deficiency and HF diet on the redox 
homeostasis of the skeletal muscle, by measuring lipid peroxidation (thiobarbituric acid 
reactive substance; TBARS), protein oxidative modifications (3NT, 4-HNE), DNA 































































damage (by means of Ogg1 relative mRNA expression) and ROS production 
(Dihydroethidium; DHE staining).  
Skeletal muscle TBARS levels were significantly increased in the WT HF diet group 
compared to the WT ND group which is in line with previous evidence 35. In contrast, 
HF diet CD36 KO mice showed TBARS level comparable to the CD36 ND and WT ND 
control group (Figure 3A). 4-HNE protein adducts were significantly higher in WT HF 
mice compared to WT ND (Figure 3B, C). However, CD36 KO mice fed a HF diet 
showed no sign of elevated 4-HNE protein adducts when compared to their CD36 KO 
ND littermates or WT ND mice. Similarly, WT HF diet mice displayed an increase in 
3NT levels (Figure 3B, D), which is an indirect marker of increased ROS levels, 
leading to increased protein oxidative modification. Moreover, CD36 KO mice under 
HF diet had similar 3NT levels to WT ND and CD36 KO ND groups. 
We next determined the relative mRNA expression levels of 8-Oxoguanine 
glycosylase (Ogg1; DNA repair enzyme), Nicotinamide adenine dinucleotide 
phosphate oxidase 2 (Nox2; oxidative stress marker), Catalase, Peroxiredoxin-1 and 
microsomal Glutathione S-Transferase 1 (Cat, Prdx1, Mgst1, Sod1; antioxidant genes) 
by qRT-PCR. There were no significant changes between any of the cohorts in the 
relative mRNA expression level of DNA-repair gene Ogg1, nor the oxidative-stress 
marker Nox2 (Figure 3E). However, the gene expression of the anti-oxidant enzyme 
Catalase was significantly upregulated in WT HF diet (2-fold), CD36 KO ND (1.4- fold) 
and CD36 KO HF diet (2.2-fold) animals when compared to WT ND (Figure 3F). 
Furthermore, we found increased mRNA levels of the antioxidant gene Prdx1, Mgst1 
and Sod1 in CD36 KO on a HF diet when compared to WT ND and CD36 KO ND 
(Figure 3F). 































































We next aimed to investigate the impact of increased fatty acid availability on oxidative 
stress levels in myotubes derived from satellite cells. Following 5 days of myoblast 
differentiation, myotubes from WT and CD36 KO animals were treated with palmitate 
(PA) and stained with DHE as an indicator for ROS production. We found a 
significantly increased number of DHE positive (+ve) myoblast nuclei in WT cell 
cultures treated with palmitate, compared to WT DM and CD36 KO cells treated with 
PA for 24 hours. CD36 KO cultures had significantly lower DHE levels compared to 
WT myotubes which was confirmed in vivo on EDL muscle sections (Figure 3G, H 
and Supplementary Figure 3). Similarly, WT myotube cultures treated with PA had 
significantly increased numbers of DHE+ve nuclei per myotube when compared to WT 
DM or CD36 KO treated with PA (Figure 3G, H). Moreover, the nuclear size was 
significantly lower in WT myotubes treated with PA but not in CD36 KO cultures treated 
with PA (Figure 3H). Shrinking nuclear size has been previously correlated with 
hypoxia-induced cell death 36. Taken together, these data suggest that ectopic fat 
accumulation in skeletal muscle of WT mice is primarily linked to increased oxidative 
stress, while skeletal muscle of CD36 KO mice is protected from oxidative stress, 
partly due to increased antioxidant enzyme activity. 
CD36 KO satellite cells maintain their proliferative capacity but have 
compromised differentiation after a high-fat diet. Given that lipid accumulation in 
the skeletal muscle is primarily involved in increased oxidative stress, we next aimed 
to examine the impact of HF diet on the satellite cell function on cultured mature 
muscle fibres stained for Pax7, MyoD and Myogenin. We found that the total satellite 
cell number and the ratio of myonuclei per satellite cell were similar at baseline among 
the experimental groups independent of diet or genotype (0 hours). However, the total 
number of satellite cells was significantly lower in the WT HF diet group compared to 































































WT ND, CD36 KO ND and CD36 KO HF diet animals after 24 and 48 hours of culture 
(Figure 4A-D). Whilst both CD36 KO ND and CD36 KO HF diet groups showed no 
sign of decreased total satellite cell number up to 48 hours of culture, we found a 
significant decrease in satellite cell number at 72 hours of culture in all groups 
compared to WT ND (Figure 4C). These results suggest that long-term HF diet 
feeding has a negative impact on satellite cell proliferation and commitment to 
differentiation, which is linked to fatty acid uptake via CD36. Taken together, CD36 
appears to play a key role during myocyte terminal differentiation, indicated by the 
diet-independent decrease in satellite cell number at 72 hours in the CD36 KO 
animals. 
Isolated satellite cells from CD36 KO mice have impaired myogenic capacity. 
Given the impaired satellite cell function on single fibres after 72 hours cell-culture in 
response to HF diet and CD36 deficiency, we next studied the function of CD36 in 
isolated satellite cells from the EDL and BB muscles in vitro (Figure 5A). We observed 
severely compromised satellite cell differentiation and myotube formation in the CD36 
deficient culture after 5 days of induced differentiation, evidenced by a significantly 
lower Myogenin/DAPI (%) ratio (Total of DAPI stained nuclei divided by all myogenin+ve 
nuclei) as well as a significantly lower fusion index (FI; Myogenin+ve nuclei inside 
mature myotubes divided by total DAPI) (Figure 5B). Not only do these results 
suggest a severely impaired differentiation of satellite cells derived from CD36 
deficient mice, but also indicate a deficit in myotube formation. These findings were 
obtained in independent experiments of satellite cells from both the EDL and BB 
muscle. 
We next examined the expression profile of genes involved in the maturation and 
fusion of satellite cells during the early (i.e. 1 day in differentiation medium) and late 































































differentiation (i.e. 5 days in differentiation medium) by qRT-PCR and MAPKs 
phosphorylation by a proteome profiler array. Relative mRNA expression of Myogenin, 
myoblast fusion factor/myomaker (Tmem8c), skeletal muscle alpha-actin (Acta1), 
Myosin heavy chain type I (Mhc1), Serum response factor (Srf), and Brain expressed 
x-linked gene 1 (Bex1) revealed a significant decrease in the mRNA levels of Srf and 
Bex1 during late differentiation of satellite cells isolated from CD36 deficient mice 
(Figure 5C). Impaired myogenic differentiation of CD36 KO isolated satellite cells was 
also confirmed by impaired protein levels of Desmin, SRF and BEX1 (Supplementary 
Figure 4). In addition, MAPKs phosphorylation levels were overall decreased in CD36 
KO HF muscle lysates with the exception of p38αT180/Y182 which was 6-fold higher than 
CD36 KO ND (Supplementary Figure 5). These results suggest that CD36 plays a 
crucial role during satellite cell terminal differentiation and maturation with possible 
implications for skeletal muscle regeneration. 
Palmitate treatment and CD36 deficiency independently compromise the 
differentiation capacity of isolated satellite cells in culture. To further study the 
effects of CD36 and/or increased fatty-acid availability on muscle stem cell 
differentiation, we treated isolated satellite cells from WT animals with the potent and 
irreversible CD36 inhibitor Sulfo-N-succinimidyl oleate (SSO). Once confluent the cells 
were further treated with palmitate (PA) to mimic the HF diet condition in a cell culture 
setting. Co-immunostaining of Myogenin and DAPI was used to identify differentiated 
satellite cells (Figure 6A). After 5 days of culture in differentiation medium, we found 
a significant decrease in the number Myogenin positive nuclei in satellite cells isolated 
from WT mice when treated with PA or SSO+PA and CD36 KO +/-PA, compared to 
WT (Figure 6B). Furthermore, we assessed the fusion index (FI), calculated by the 
number of Myogenin+ve nuclei inside mature myotubes divided by total DAPI. We found 































































a significantly lower fusion index in satellite cells from WT+PA, CD36KO, CD36 
KO+PA as well as in WT+SSO +PA groups, indicating that both PA treatment and/or 
CD36 deficiency lead to impaired myoblast fusion (Figure 6C). These data further 
support our previous findings, suggesting that both CD36 deficiency and increased 
fatty acid availability negatively impact satellite cell differentiation. 
Oxidative stress has been reported to impact on muscle stem cell activity and 
myogenic potential 37. We therefore studied muscle stem cell differentiation under 
palmitate treatment in response to two substances with known antioxidant properties 
(i.e. Ebselen and TEMPOL 38. We found that palmitate increased DHE and decreased 
MHC levels in WT but not CD36 KO cultures of isolated satellite cells which were 
reversed by the use of Ebselen and TEMPOL (Supplementary Figures 6). The 
findings were also confirmed through DHE and myogenin staining in single fibre 
cultures (Supplementary Figures 7). These data indicate that treatment with 
antioxidant substances do not rescue CD36 KO myoblast differentiation in response 
to palmitate but are important for the WT cohorts.
Isolated CD36 KO and WT satellite cells have distinct bioenergetic profiles in 
response to palmitate treatment. Recent reports demonstrated that mitochondrial 
activity is associated with specific lineage decision 39. We wished to determine if CD36 
deficiency alters mitochondrial function in undifferentiated and mature, differentiated 
satellite cells. Further we aimed to investigate the bioenergetic profile in the presence 
or absence of high free fatty acid availability. To investigate this, we cultured isolated 
satellite cells from WT and CD36 KO mice in a Seahorse extracellular flux culture plate 
and used the oxygen consumption rate (OCR) to measure mitochondrial respiration in 
satellite cells (Figure 7A). Undifferentiated primary myoblasts (i.e. 1 day after 
isolation) revealed no significant difference in the basal OCR or coupling efficiency 































































(i.e. Basal OCR minus OCR after Oligomycin injection; Proton leak) (Figure 7B, C). 
Although the maximum respiratory capacity showed no difference between WT and 
CD36 deficient cells, the spare respiratory capacity (SRC) in CD36 deficient cells was 
significantly higher than in the WT cells, indicating that mitochondrial bioenergetics are 
altered and CD36 deficient cells are more resistant to stress, further supporting the 
concept that the CD36 deficient cells have an increased ability to adapt to stressful 
conditions. We found no difference in the non-mitochondrial respiration (Non-mit. 
Resp.), but a significant reduction in ATP production in the CD36 KO-derived satellite 
cells compared to WT-derived satellite cells (Figure 7B, C). We further aimed to 
establish the effect CD36 on mitochondrial function during satellite cell differentiation 
in the presence or absence of palmitate. We therefore cultured satellite cells in a 
seahorse extracellular flux cell culture plate until confluent and subsequently changed 
to differentiation medium (DM). Following differentiation (5 days DM) WT myotubes 
showed a significant increased basal respiration when treated with palmitate, whilst 
CD36 deficient myotubes revealed a reduction in the basal OCR compared to WT 
untreated mitochondria. The addition of the ATP synthase inhibitor Oligomycin 
(complex V inhibitor) decreased the OCR following injection, revealing an increased 
Proton leak (i.e. Basal OCR minus OCR after Oligomycin injection) in WT derived 
satellite cell mitochondria when treated with palmitate. Subsequently FCCP, an 
uncoupling agent, was injected to measure maximal oxygen consumption (i.e. 
complex IV). The addition of FCCP showed comparable maximal respiration (Max. 
Resp.) as well as unaltered spare respiratory capacity in all groups (Figure 7D, E). 
Interestingly, palmitate treatment had adverse effects on WT and CD36 deficient 
myotubes, increasing the spare respiratory capacity (SRC) in WT but decreasing SRC 
in CD36 deficient myotubes, depicted by the steep rise of OCR in the WT+PA group, 































































peaking shortly after the FCCP injection. Interestingly, the addition of FCCP did not 
lead to a further increase of the OCR in the CD36 KO+PA condition when compared 
to CD36 KO OCR (Figure 7E). We found ATP production to be elevated only in the 
WT+PA condition (Figure 7D, E). In all, our data suggests that myotube mitochondria 
have an altered bioenergetic response in the presence of palmitate which seems to 
be, at least partly, regulated through CD36. 
CD36-deficiency results in delayed skeletal muscle regeneration following acute 
injury with cardiotoxin. Having shown that CD36 KO derived satellite cells exhibit 
reduced commitment to differentiation, we next examined the impact of CD36 
deficiency on skeletal muscle regeneration in vivo. Regeneration of skeletal muscle is 
mainly driven by a highly orchestrated process involving the activation, proliferation, 
differentiation and fusion of satellite cells 40. Following cardiotoxin (CTX) injection in 
the tibialis anterior, necrotic tissue and damaged fibres are replaced by newly formed 
fibres expressing embryonic myosin heavy chain (eMHC). Here we show that the 
cross-sectional area (CSA) of early regenerating fibres expressing (eMHC+ve at day 5) 
was comparable between WT and CD36 KO mice (Figure 8A). However, the 
clearance of necrotic fibres (by means of IgG infiltration) was significantly impaired in 
CD36 KO mice when compared to WT animals at 5 days after the CTX injury. Along 
with this finding we show a significant decrease in macrophage infiltration and muscle 
progenitor cell density expressing Myogenin (but not MyoD) in CD36 KO mice 5 days 
after CTX injury (Figure 8A and Supplementary Figure 8). Furthermore, we found 
significantly smaller CSA of regenerating fibres 10 days after CTX injection (Figure 
8B, D) in CD36 KO mice. In line with this observation, we report that regenerating 
fibres expressing eMHC were absent in WT but still present in CD36 KO mice 10 days 
after CTX injury. Taken together, these data suggest delayed skeletal muscle 































































regeneration in CD36 KO mice based on higher frequency of necrotic fibres, reduced 
CSA of regenerating fibres and decreased macrophage infiltration.  
CD36 KO mice develop hepatic steatosis in response to high-fat diet. 
Additionally, we aimed to determine the impact of CD36 deficiency on the liver of the 
CD36 KO mouse. WT mice on a HF diet showed a significant increase in lipid 
accumulation in the liver as shown by Oil red O staining compared to WT and CD36 
KO mice on a standard chow. Remarkably, CD36 KO mice exhibited a significant 
increase of lipid accumulation compared to all other groups, as evidenced by the larger 
lipid number as well as lipid size (Figure 9A-B). These findings were supported by 
quantifying hepatic TG accumulation using gas chromatography. However, total 
phospholipid content was not affected by either genotype or diet (Figure 9C). These 
results prompted us investigate expression profiles of genes involved in fatty acid 
transport and metabolism in the liver. Levels of relative mRNA expression of Fatty acid 
transporter proteins 1,2,3 and 5 (Fatp1,2,3,5) and Pparγ as well as cell death-inducing 
DNA fragmentation factor α-like effector A (Cidea) were quantified. Fatp2, Fatp1 and 
Pparγ were significantly increased in CD36 KO HF diet animals when compared to 
WT ND mice. Most strikingly, we found that expression of Cidea, which has been 
shown to regulate lipolysis and lipid fusion 41,42, was increased 25-fold in CD36 KO 
mice compared to control mice (Figure 9D). Collectively, this data indicates opposing 
effects of CD36 deficiency with a protective role in the skeletal muscle due to reduced 
lipid accumulation, but at the same time leading to excessive lipid deposition in the 
liver.































































Material and methods 
Mice. All experiments were in accordance with UK Animals Scientific Procedures Act 
1986. This study was carried out on male Wild-type (WT; C57/Bl6) and CD36 knockout 
(KO) mice. Whole-body CD36 KO mice were previously created via targeted 
homologous recombination. Exon3, which contains the first 40 amino acids of CD36, 
was deleted entirely in the homologous recombined allele 43. Mice were maintained in 
a temperature- and humidity-controlled facility with 12/12 h light/dark cycle and had ad 
libitum access to water and food. At 2-3 months of age, a subset of mice was randomly 
distributed into a standard laboratory chow group (product “5LF5-EURodent Diet 
22%”, LabDiet, St.Louis, USA) and a high-fat diet (SDS 824053 High-Fat diet, 45%, 
SDS Diets Grangemouth, Falkirk, UK) group for a period of 13 weeks. Mice were then 
sacrificed using a CO2 overdose. Muscle, adipose, heart and liver tissue were excised, 
weighed, snap frozen and covered in optimum cutting temperature embedding 
compound (OCT) and stored at -80°C until further use.
Single fibre isolation and cell culture. Single muscle fibres were obtained by precise 
dissection of the Extensor digitorum longus (EDL) and the Biceps Brachii (BB) muscle, 
followed by collagenase digestion (0.2%; Sigma Aldrich; cat. C2674) as previously 
described 44. Briefly, following collagenase digestion, the muscle tissue was 
transferred into a horse serum (Gibco) coated petri dish and triturated using a wide-
bore glass pipette to dissociate individual fibres. Floating single fibres were then 
cultured for 24, 48 or 72 hours in growth medium (GM; 10% horse serum, 0.5% 
chicken embryo extract) ± Palmitate (0.3mM) ± Ebselen (20μM; cat. E3520-100MG, 
Sigma, UK). Subsequently the fibres were stained for the satellite cell-specific markers 
Pax7 (1:200, mouse monoclonal anti-Pax7, Santa Cruz, cat. Sc81648), MyoD (1:200, 
rabbit polyclonal anti-MyoD, Santa Cruz, cat. sc-760) and Myogenin (1:200, rabbit 































































polyclonal anti-Myogenin, Santa Cruz, cat. sc-576); nuclei were counterstained using 
4,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich, UK). Satellite cell expression 
profiles from isolated single fibres (N=50 per condition) was assessed using N=5 
animals per group. 
Satellite cell isolation from single fibres. Primary myoblasts were derived from 
isolated single fibres after collagenase digestion as described above. Subsequently, 
the fibres were incubated in 1mL 0.125% Trypsin-EDTA for 5 minutes and centrifuged 
at 210 x g. Cells were suspended in 3mL Satellite cell proliferation medium (PM; 30% 
Foetal bovine serum, 1.5% chicken embryo extract in Dulbecco’s Modified Eagles 
Medium, high glucose, Pyruvate supplemented) and were transferred into Matrigel-
coated cell culture dishes (cat. 354234, Corning, Bedford, USA, final concentration 
1mg ml-1), followed by a three-day incubation. Subsequently, floating single fibre 
fragments were removed, medium was changed to growth medium (GM; 10% Foetal 
bovine serum, 0.5% chicken embryo extract in DMEM) and isolated satellite cells were 
cultured until they reached 80% confluence. Each preparation typically yields 2-3 x105 
cells per cell culture dish (originating from approximately 800 fibres). Induced primary 
myoblast differentiation was achieved through changing the GM to differentiation 
medium (DM; 5% horse serum, 0.5% chicken embryo extract in DMEM) for 5 
subsequent days. Palmitate treatment was performed using 0.3mM final concentration 
and Sulfo-N-succinimidyl oleate (SSO) induced CD36 inhibition at a final concentration 
of 0.25mM. Cellular antioxidant experiments were conducted with ± Palmitate (0.3mM) 
± Ebselen (20μM) ± TEMPOL (1mM; cat. 176141-25G, Sigma, UK). Cells were fixed 
and differentiation confirmed visually by staining for Myogenin (1:200, rabbit polyclonal 
anti-Myogenin, Santa Cruz, cat. sc-52903). Nuclei were counterstained with DAPI 
(DAPI, Sigma Aldrich, UK). Digital images were obtained using a Zeiss AxioImager.A1, 































































HBO 100 fluorescent microscope. The Myogenin/DAPI ratio and the fusion index (i.e. 
Myogenin+ve nuclei inside myotubes/total DAPIx100) were calculated using the ZEN 
Image software.
Immunohistochemistry. Muscle tissue (TA, EDL, Sol) was snap frozen using 
isopentane, cooled in liquid nitrogen and sectioned (10 µm thick). Muscle sections 
were permeabilised (Triton X-100 in PBS) followed by the immunofluorescent staining 
of two different myofibre types. Primary antibodies used were MHCIIA (DSHB A4.74) 
and MHCI (DSHB A4.840) or type MHCIIB (DSHB BF.F3). Incubation with primary 
antibodies was performed at 4°C overnight. Sections were stained with corresponding 
secondary antibodies (1:200) for 1 h. Images were taken using a Zeiss Axio Imager 
A.1 microscope (Zeiss, Germany). 
BODIPY staining for muscle lipid accumulation. BODIPY staining was performed 
to examine lipid accumulation in TA muscle tissue after 13 weeks of HF diet or 
standard laboratory chow. Briefly, after cryostat-sectioning, TA tissue was incubated 
with 20µg/mL BODIPY solution (BODIPY®, 4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-
Bora-3a,4a-Diaza-s-Indacne, Fisher Scientific, UK) for 30 minutes and subsequently 
washed with PBS for 10 minutes. Nuclei were counterstained with DAPI (DAPI, Sigma 
Aldrich, UK). Digital images were obtained using a Zeiss AxioImager.A1, HBO 100 
fluorescent microscope. 
Western blotting. Protein was extracted from homogenised quadriceps muscle using 
RIPA lysis buffer 1% v/v Nonidet P40 substitute (NP-40, Sigma Aldrich, UK), 0.1% w/v 
SDS (Fisher Scientific, UK) and 0.5% (w/v) sodium deoxycholate (Sigma Aldrich, UK) 
in 50 ml PBS. Samples were centrifuged at 4°C for 15 minutes at 14,000g. 
Quantification of protein content from the supernatant was performed by Pierce BCA 
protein assay kit (Fisher Scientific, UK) according to the manufacturer’s instruction. 30 































































micrograms of protein was resolved in 10% SDS-PAGE, and immunoblotting was 
performed with the corresponding antibody. The following antibodies were used: 3NT 
(1:500; Santa Cruz; cat. 32757), 4HNE (1:1000; R&D Systems MAB3249) β tubulin 
(1:1000; EMD Millipore; cat. 05-661). Immunoblotting analysis was performed by 
probing the membranes with each antibody or β tubulin and analysed using the 
Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE). Band density 
was measured using ImageJ software. The band densities were normalized to β 
tubulin content. 
Phospho-MAPK Proteome profiler array. MAPK phosphorylation was measured 
with the phosphor-MAPK proteome profiler array following the manufacturer’s 
instructions (cat. ARY002B, R&D, UK). Pooled samples of six gastrocnemius muscles 
from WT ND, WT HF, CD36 KO ND and CD36 KO HF groups were lysed and adjusted 
to 1μg/μL. Signals were detected with chemiluminescent substrate.
Lipid peroxidation. Tissue samples were homogenised and thiobarbituric acid (TBA) 
reactive substance (TBARS) used to analyse lipid peroxidation with the OXItek TBARS 
Assay Kit (Enzo Life Science, USA) as described previously (Sfyri et al. 2018). TBARS 
were assessed in whole muscle samples. 
Dihydroethidium (DHE) staining. Plated satellite cells were washed with PBS and 
subsequently incubated with 10µM of DHE (Sigma-Aldrich 7008) for 10 minutes at 
37°C. The cells were then washed in PBS three times with each wash lasting 5 
minutes. Finally, the cells were fixed with 4% Paraformaldehyde (PFA) for 10 minutes 
and mounted in fluorescent mounting medium, using DAPI to counterstain cell nuclei.
Quantitative qRT-PCR. Total RNA was isolated from both cells and tissue as 
described previously (Paolini et al. 2018), by using the standard TRIzol method 
(AMRESCO RiboZolTMRNA Extraction Reagent) using the E.Z.N.A total RNA kit I 































































(Omega Bio-Tek, USA). Briefly, RNA was purified by DNase I treatment (Roche, 
Indianapolis, IN, USA). Reverse transcription of 2µg total RNA was performed using 
the RevertAid H MinusFirst Strand cDNA Synthesis Kit (Fisher Scientific, UK) 
according to the manufacturer’s protocol. qRT-PCR was carried out using the Applied 
Biosystems SYBRGreen PCR Master Mix (Fisher Scientific; cat. 4364344) in a 
StepOne Plus cycler (Applied Biosystems, UK). Relative gene expression was 
determined using the ∆∆CT method. Values of each RNA sample were normalised to 
cyclophilin 1 (Cyp1) and hypoxanthine phosphoribosyltransferase (Hprt) mRNA levels. 
Primer sequence list is available upon request.
Seahorse XFp extracellula  flux measurement. Isolated satellite cells were seeded 
at a density of 10,000 cells per well in 8-well XF plates pre-coated with matrigel as 
described previously 45. In brief, cells were pre-incubated in growth medium (DMEM, 
10% horse serum, 0.5% chicken embryo extract, 1% Penicillin/Streptomycin) for 24 
hours and switched to differentiation medium (DM, 2% horse serum) for 5 subsequent 
days. Prior to the experiment, sensor cartridges were hydrated with XF calibrate 
solution (pH 7.4), as recommended by the manufacturer’s instructions and 
incubated at 37°C in a non-CO2 environment for 24 hours. The cell culture medium 
was replaced with assay medium containing 1mM sodium pyruvate and incubated for 
one hour in a non-CO2 incubator. Oligomycin (1µM final concentration), carbonyl 
cyanide 4- (trifluoromethoxy)phenylhydrazone (FCCP; 5 µM final concentration) and 
Antimycin (2.5 µM final concentration) were diluted in the assay medium. The 
Seahorse XFp Analyzer (Seahorse Biosciences) was then used to measure the 
oxygen consumption rate (OCR) in real time. Baseline measurements of OCR were 
taken before sequential injection of oligomycin, FCCP and antimycin. Seahorse data 
were normalised to total protein (µg) and analysed using the Wave software from 































































Agilent Technologies. Gas chromatography. Gastrocnemius and liver lipid profiling 
was performed by using a combination of thin-layer chromatography and gas 
chromatography as previously described 32,46. Tissue was pulverised by manual 
mortar and pestle grinding in liquid nitrogen. Lipids were extracted from specimens 
with chloroform-methanol 2:1 (v/v) in the presence of 0.005% (w/v) butylated 
hydroxytoluene, as an antioxidant, and fixed amounts of triheptadecanoyl glycerol 
(Sigma, St. Louis, MO), as triacylglycerol internal standard, and diheptadecanoyl 
phosphatidyl choline (Larodan, Solna, Sweden), as phospholipid internal standard. An 
aliquot of each lipid extract was spotted on a high-performance silica gel plate 
(Macherey-Nagel, Düren, Germany), which was then developed in petroleum ether - 
diethyl ether - acetic acid 80:20:1 (v/v/v). Lipid spots were visualised under ultraviolet 
light after spraying the plate with 0.2% (w/v) dichlorofluorescein in ethanol. The 
triacylglycerol and phospholipid spots were scraped off and transferred to screw-cap 
tubes. Fatty acid methyl esters (FAMEs) were produced by the addition of 1 ml of 
methanol - sulfuric acid 96:4 (v/v) and heating at 64°C overnight. The FAMEs were 
then extracted with 1 ml of hexane and were separated in an Agilent 7890A gas 
chromatograph (Santa Clara, CA), equipped with a 30 m-long AT-WAX capillary 
column (Alltech, Deerfield, IL) and flame ionization detector. The column temperature 
was programmed from 140° to 270°C at 40°C min−1 and the run was held at 270°C for 
4 min. The carrier gas was helium at a flow rate of 1.6 ml min−1. FAMEs were quantified 
in the chromatograms obtained with the aid of the Agilent ChemStation software by 
comparing the area under their peaks to that of methyl heptadecanoate (derived from 
the internal standards).
Cardiotoxin (CTX) induced muscle injury in vivo. Tibialis anterior (TA) muscle 
injury was induced as previously described 45. Briefly, mice were injected with a total 































































of 30µL, 50 µmol/L Naja pallida CTX (Latoxan, Valence France) into the TA muscle. 
Mice were humanely euthanized 5- and 10-days post-injury and the TA muscles were 
collected for subsequent immunohistochemistry. 
Oil Red O staining for liver lipid accumulation. Oil Red O staining was performed 
to examine lipid accumulation in liver tissue after 13 weeks of HF diet or standard 
laboratory chow. In short, after cryostat-sectioning, liver tissue was fixed in 4% 
paraformaldehyde, briefly washed and subsequently incubated with the Oil Red O 
solution (Fisher Scientific, UK) for 10 minutes and counterstained with haematoxylin 
(Sigma Aldrich, UK). Lipid deposition was confirmed visually. The area of Oil Red O 
staining was analysed using three fields of view for each liver taking into account lipid 
size and frequency.
Statistical analysis. Differences between two groups were detected by Student’s t-
test. Statistical significance in experiments comparing more than 2 groups was 
determined by two-way ANOVA (genotype x diet), followed by Tukey post hoc test. 
For the detection of differences in lipid size analysis as well as CSA, the Chi square 
(χ2) test was performed. All significant differences (p<0.05) are given in the figures 
and/or figure legends. Statistical analysis was carried out using Graph Pad Prism 
(GraphPad Software, CA, USA) or IBM SPSS software (IBM SPSS Statistics version 
24). Significant differences were considered for p<0.05. 
































































Satellite cells, the myogenic precursor stem cell population of the skeletal muscle, are 
of pivotal importance for skeletal muscle homeostasis and regeneration 2. Sparse 
evidence suggests that skeletal muscle regeneration is severely impaired in obese 
individuals possibly due to increased lipid deposition and perturbed satellite cell 
function 7,10,27,47. The fatty acid transporter CD36 plays an important role in skeletal 
muscle fatty acid transport and utilisation 22,24,48. In this study, we show that CD36-
deficient mice are protected from HF diet-induced weight gain, which is in line with 
previous findings 49,50, but results in impaired satellite cell function, compromised 
myogenic differentiation, delayed muscle regeneration after acute injury and hepatic 
steatosis.
Enhanced lipid storage and accumulation in adipose and skeletal muscle lead to the 
development of obesity and insulin resistance 51,52. Our findings of decreased fatty 
acid uptake and accumulation in the CD36 KO skeletal muscle under HF diet highlight 
the importance of CD36 for skeletal muscle energy homeostasis. Upregulation of 
alternative fatty acid transporters, such as Fabp3 in CD36 KO mice on a HF diet, was 
not sufficient to compensate for the defect in fatty acid uptake due to the loss of CD36. 
Furthermore, skeletal muscle metabolism seemed to be altered, revealing increased 
myokine mRNA levels such as Fndc5 and IL-15, which have been shown to be 
increased in skeletal muscle in response to exercise and downregulated in diabetic 
conditions 53.
Limited data suggest that skeletal muscle ectopic lipid infiltration impairs satellite cell 
activation leading to a decrease of skeletal muscle regeneration potential 7,27. We 
observed a significant reduction in cultured satellite cell numbers in WT HF diet mice. 
Moreover, we showed that obesity impairs satellite cell activation during early 































































proliferation (i.e. 24h). The fact that satellite cell numbers were unaffected in CD36 
deficient mice further supports our hypothesis that obesity impairs satellite cell function 
via CD36-dependent pathways. Unexpectedly, significantly lower satellite cell 
numbers were observed in CD36-deficient mice during differentiation independent of 
diet, indicating the importance of CD36 during skeletal myogenesis 54. This was 
confirmed by the deficit in myogenesis of isolated satellite cells from CD36-deficient 
mice in vitro. In line with our findings are the observed effects of palmitate on 
differentiation of skeletal muscle stem cells. It has been shown that palmitate inhibits 
differentiation through a decrease in cyclin A and cyclin D1 levels 55. Our data also 
suggest that compromised myogenic differentiation in response to dietary cues and 
increased ROS can be rescued by antioxidant treatment in WT but not CD36 KO 
muscle stem cells.
MAPKs play important roles in cell differentiation, fusion and myogenesis such as 
Akt1, Erk1/2, GSK3α/β, JNK1, HSP27 and p38α 56-59. Changes in phosphorylation 
levels of the above kinases seen in CD36 KO HF mice may, at least in part, explain 
the impaired myogenic differentiation reported here. Similarly, p38α levels and the 
p38α downstream target HSP27 were found to be hypo-phosphorylated in CD36 KO 
ND mice, but HSP27 phosphorylation by p38α is required for differentiation 58. 
Together, these observations suggest an important role of p38α and HSP27 in the 
defective myogenesis of CD36 KO mice.
We further consolidated our hypothesis by quantifying gene expression of myogenic 
markers. We found reduced Bex1 mRNA levels in differentiated satellite cells from 
CD36-deficient mice. Interestingly, Bex1-deficiency has been associated with 
prolonged proliferation and delayed differentiation following recovery after myotrauma 
60. One possible explanation for the involvement of CD36 in skeletal myogenesis is its 































































interaction with AMPK. CD36 has been shown to inhibit AMPK activation and in the 
absence of CD36, AMPK has been shown to be constitutively active in muscle 61. This 
could possibly lead to the activation and proliferation of satellite cells via non-canonical 
Sonic Hedgehog signalling which induces Warburg-like glycolysis in satellite cells, 
required for their activation and proliferation during muscle regeneration 62. AMPK also 
inhibits myoblast differentiation through PGC-1alpha-dependent pathways 63. 
Moreover, AMPK has been shown to inhibit mTOR signalling 64, via the AMPK-Nampt-
Sirt1 pathway 65, resulting in the inhibition of differentiation. This line of thought offers 
a plausible explanation for the adverse effect of CD36 deficiency on satellite cell 
proliferation and differentiation. 
Mitochondrial dysfunction has been observed in several diseases related to the 
metabolic syndrome and is one of the most prominent abnormalities found in skeletal 
muscle of obese and diabetic individuals 66-68. CD36 is involved in mitochondrial fatty 
acid oxidation, translocating from the cytoplasm to the mitochondrial plasma 
membrane during muscle contraction 69. To assess whether loss of CD36 changes 
mitochondrial function in the presence of free fatty acids, we analysed the oxidative 
capacity and the bioenergetic profile of isolated satellite cells during proliferation and 
differentiation. In our study, proliferating satellite cells from CD36-deficient mice had a 
significantly increased spare respiratory capacity (SRC). SRC is a critical factor 
implicated in cell survival and function, reflecting the ability of mitochondria to maintain 
energy production in response to an increase in energy demand, like in acute or 
chronic stress 70. These findings further support the notion that proliferating satellite 
cells from CD36-deficient mice have an increased ability to adapt to stressful 
conditions such as FCCP treatment. 































































We further report a decrease in ATP production in proliferating, CD36 KO derived 
satellite cells compared to WT-derived satellite cells. Stem cells have a low demand 
in ATP, which has been linked to preserved stemness 71. A possible explanation is 
that, in order to produce ATP, mitochondria must utilise a substrate such as fatty acids. 
The reduced capacity of satellite cells from CD36 KO mice to use fatty acids for ATP 
production may explain the lower ATP levels during stimulated respiration 72. Part of 
the myoblast differentiation process into myotubes is the extensive remodelling of the 
mitochondrial network. It has been proposed that, alterations in the remodelling of the 
mitochondrial network during the transition from proliferation to differentiation can lead 
to the diminished ability to regenerate muscle tissue 72. Given the underlying 
reformation of the mitochondrial network during myogenesis, we aimed to analyse the 
mitochondrial function of differentiated satellite cells in the presence or absence of 
palmitate (i.e. a free fatty acid). During differentiation, the oxygen consumption rate 
(OCR) has been shown to increase significantly as a result of the elevated energy 
demand 73. In line with previously published data 74 we report here, that isolated WT 
satellite cells show a significant increase of maximal oxygen consumption during the 
transition from proliferation to differentiation. However, CD36 KO derived satellite cells 
were unable to increase their OCR during the process of differentiation. This finding 
provides a plausible explanation for the impaired differentiation of satellite cells from 
CD36 KO animals reported in this study. Furthermore, treatment with palmitate-
induced opposing effects between satellite cells isolates from WT and CD36 KO mice, 
resulting in increased OCR only in the WT, suggesting that CD36 is a key regulator of 
β-oxidation in satellite cells 75. It appears that impaired myogenic differentiation with 
palmitate under CD36 deficiency is not affected by ROS levels, but rather perturbed 
bioenergetics due to inability to increase OCR. This notion is strengthened by previous 































































evidence showing that palmitate-induced mtDNA damage in skeletal muscle cells had 
deleterious effects on mitochondrial respiration 76. 
Here we show that CD36-deficiency impairs muscle regeneration following CTX injury, 
evidenced by an increased occurrence of necrotic fibres and reduced CSA in the 
injured muscle of CD36 KO mice. Along with this, our results show a significant 
decrease in macrophage infiltration in CD36 KO mice 5 days after CTX injury. This is 
in agreement with previous data showing impaired macrophage phagocytic capacity 
in cardiac tissue due to CD36 inhibition 77. This notion is further supported by the 
attenuated phagocytosis seen in pharmacological inhibition of CD36 which plays an 
important role during tissue repair and the resolution of inflammation 78. CD36 has 
been found to be crucial for M2 macrophage polarization, involved in the transition 
from the M1 (pro-inflammatory) to the anti-inflammatory response marked by M2 
macrophages, indicating that CD36-mediated uptake of triacylglycerol is crucial for M2 
activation 79. In addition, recent data on reduced tissue infiltration of macrophages in 
a model of cell-restricted deletion of CD36 suggests an important immune-regulatory 
function of CD36 80. In fact, CD36 is involved in the signalling cascades that allow 
macrophages to recognise cells undergoing apoptosis. Recognition and attachment 
of macrophages to apoptotic cells further involves ROS-induced lipid and protein 
oxidation which suggests another important mediatory role of CD36 in ROS dependent 
macrophage-driven phagocytosis 81,82. Collectively, these data show that CD36 plays 
a crucial role in macrophage tissue infiltration and ROS dependent recognition of 
apoptotic cells with a crucial role for the post-inflammatory resolution phase and debris 
removal, important for the regenerative process after acute skeletal muscle injury 78. 
This outcome is in line with our in vitro data in this study, showing impaired 
differentiation capacity in satellite cells isolated from CD36 KO mice. Furthermore, we 































































found significantly reduced CSA in CD36 KO mice 10 days following CTX injection. 
This is followed by increased expression of eMHC in CD36 KO compared to WT mice, 
suggesting delayed regeneration 10 days after muscle injury. We demonstrate that the 
impaired regeneration seen in vivo is at least in part brought about by the reduced 
stem cell commitment to differentiation seen in isolated satellite cells.
CD36 deficiency is known to result in hyperlipidaemia under both standard or a high 
fat diet (Supplementary Table 1). The CD36 KO mouse maintained on a HF diet had 
decreased levels of fatty acid accumulation in the skeletal muscle, however, adverse 
effects were seen in the liver tissue, evidenced by large lipid-droplets associated with 
hepatic steatosis. These findings parallel previously published results showing that 
CD36 deficiency in mice increases skeletal muscle insulin sensitivity in skeletal 
muscle, but induces insulin resistance in the liver 83,84. FATP1, a member of the 
FATP/Slc27 protein family, is an insulin-sensitive fatty acid transporter. It has been 
shown to translocate from the intracellular compartment to the plasma membrane in 
response to insulin and to be involved in the re-distribution of lipids from adipose and 
skeletal muscle tissue to the liver. A significant observation in the present study is that 
liver Fatp1 mRNA contents are 2.3- and 3.6-fold higher in CD36 KO versus WT HF 
and WT ND mice respectively. We conclude that in CD36 deficient mice, upregulation 
of FATP1 plays a key role in the development of hepatic steatosis in the presence of 
elevated free fatty acid availability. Our findings mirror the observation made in human 
CD36 deficiency, showing impaired fatty acid uptake by the heart but no restriction in 
the liver 85,86. It has been suggested that in CD36-deficient humans may lead to 
increased postprandial fatty acid uptake in tissues that do not depend on CD36, such 
as the liver, resulting in lipid overload and the development of insulin resistance 86. 































































Our findings identify FATP1 as a potential target to prevent lipid overload to the liver 
in CD36 deficiency.
Our investigations further revealed a more than 20-fold increase in the expression 
level of Cidea in liver from CD36 KO mice on a high-fat diet compared to WT HF fed 
animals. Cidea is involved in energy expenditure and obesity and has been described 
to inhibit lipolysis 41. Cidea KO mice exhibit higher energy expenditure, increased 
lipolysis in brown adipose tissue and are resistant to HF diet-induced obesity 87. This 
supports our interpretation that CD36-deficient mice develop hepatic steatosis since it 
is known that Cidea positively correlates with lipid droplet enlargement, fusion and the 
development of fatty liver disease 88. The development of non-alcoholic fatty liver 
disease (NAFLD) is one of the many complications associated with obesity and the 
development of diabetes. Here we report an important link between CD36 and Cidea 
with potential implications in the management of NAFLD. Furthermore, CD36 
expression has been shown to be associated with tissue inflammation 89 and increased 
oxidative stress 33. In the present study we show that markers of oxidative stress in 
skeletal muscle are reduced, paralleled by increased antioxidant enzyme gene 
expression in CD36-deficient mice under HF-diet, suggesting improved redox 
homeostasis. These findings are in line with recently published data showing 
decreased obesity-associated oxidative stress in the hearts of CD36-deficient mice 33.
In conclusion, we show that CD36-deficiency protects mice from diet-induced weight-
gain. CD36 KO mice on a HF diet demonstrated decreased skeletal muscle lipid 
accumulation, suggesting CD36 as an important link between lipotoxicity and oxidative 
stress in obesity. Our study provides new insights for the involvement of CD36 in the 
development of hepatic steatosis, establishing Fatp1 and Cidea as potential 
therapeutic targets. This study further elucidates the complexity of the underlying 































































alterations in mitochondrial fatty acid oxidation and bioenergetics related to obesity, 
supporting evidence of the contribution of CD36 to the development of the metabolic 
syndrome. Most importantly, CD36-deficient mice exhibited impaired satellite cell 
differentiation and skeletal muscle regeneration, which identifies CD36 as a key 
regulator of these processes. Further research will be necessary to clarify the 
underlying mechanism of impaired skeletal muscle regeneration in the absence of 
CD36 to provide a basis to better understand the link between CD36-mediated skeletal 
muscle lipid metabolism in the context of muscle regeneration in obesity. 
































































Figure 1. CD36-deficient mice show reduced body weight gain upon high-fat diet 
compared to wild-type mice. (A) Schematic outline of dietary intervention and single 
muscle fibre isolation for muscle stem cell cultures in subsequent experiments; control 
diet (ND), high-fat (HF) diet in Wild-type (WT) and CD36 Knockout (KO) mice. (B) 
Representative images of WT and CD36 KO mice subjected to a ND and HF diet. (C) 
Body weight changes in WT and CD36 KO mice fed a ND or a HF diet for 13 weeks. 
(D) Final body weight (i.e. week 13) of mice fed a ND or HF diet. Data are mean±SD 
(N=8 per group). Statistical analysis was performed by three-way ANOVA, *p˂0.05 vs. 
WT ND, #p˂0.05 vs. WT HF.
Figure 2. Effect of CD36 deficiency and high-fat diet on lipid accumulation in 
skeletal muscle. (A) Skeletal muscle lipid accumulation in WT and CD36 KO mice on 
either ND or HF diet was detected by BODIPY staining (20x, scale bar=100µm). (B) 
Quantification of fluorescence intensity shown in arbitrary units (a.u.) of pixel intensity. 
(C) Gas chromatography was performed in skeletal muscle, quantifying the 
triacylglycerol (TG) and phospholipid (PL) content (µmol/g). (D) Relative gene 
expression in skeletal muscle was analysed by qRT-PCR. Data are mean±SD (N=6) 
per group. Statistical analysis was performed by two-way ANOVA, *p˂0.05 vs. WT 
ND, #p˂0.05 vs. WT HF bp˂0.05 vs. CD36KO ND, $p˂0.05.
Figure 3. CD36 deficiency attenuates high-fat diet-induced protein modification 
and increases antioxidant gene expression in skeletal muscle. (A) Skeletal 
muscle lipid peroxidation was analysed using TBARS. (B-D) Skeletal muscle oxidative 
protein modification for 4-HNE adducts and 3NT was assessed in quadriceps (QD) 
muscle by western blotting. (E-F) Relative gene expression in skeletal muscle for 
genes involved in DNA repair and redox equilibrium. (G) Representative images of 































































DHE staining to assess ROS production in isolated satellite cells, cultured in 
differentiation medium for 5 days in the absence or presence of palmitate (PA). (H) 
Quantification of total DHE+ve nuclei/total DAPI, DHE+ve nuclei/myotube/total DAPI and 
nuclear size (µm2) with *p˂0.05 vs. all other experimental groups. Data are 
represented as mean±SD (N=5-6) per group. Statistical analysis was performed using 
two-way ANOVA, *p˂0.05 vs. WT ND, #p˂0.05 vs. WT HF, bp˂0.05 vs. CD36 KO ND, 
¥p˂0.05 vs. every other group.
Figure 4. High-fat diet and CD36 deficiency independently attenuate satellite cell 
proliferation on single fibres. (A) Representative pictures show EDL satellite cell 
immunostaining for Pax7 and Myogenin counterstained with DAPI. (B-C) Quiescent 
satellite cells were identified 0 h (0 hours) and quantified using immunostaining for 
Pax7. Satellite cell proliferation after 24 h and 48 h (24 and 48 hours) was quantified 
by Pax7 and MyoD, and differentiation after 72 h (72 hours) by Pax7 and Myogenin 
immunostaining. (D) Myonuclei to satellite cell (SC) ratio of the myofibres for WT and 
CD36 KO mice fed ND of HF at 0 h. Data are represented as mean±SEM (N=8 mice 
per condition; 50-70 individual myofibres were counted). Statistical analysis was 
performed using two-way ANOVA, *p˂0.05 vs. WT ND, #p˂0.05 vs. every other group.
Figure 5. CD36 is important for satellite cell differentiation and skeletal 
myogenesis. Immunohistochemistry was performed on isolated, plated satellite cells 
from EDL and BB in proliferation medium (PM) and cultured in growth medium (GM). 
(A) Schematic of satellite cell isolation-protocol from muscle tissue. (B) Differentiation 
was quantified after changing the GM to differentiation medium (DM) for 5 subsequent 
days. Satellite cells were immunostained for Myogenin and nuclei counterstained 
using DAPI. Differentiation was determined as Myogenin/DAPI (%) and the fusion 
index as Myogenin+ve nuclei inside myotubes divided by total DAPI. (C) Relative gene 































































expression by qRT-PCR for genes regulating skeletal myogenesis. Data are 
represented as mean±SD (N=3-4 technical replicates, 2 independent experiments) per 
group. Statistical analysis was performed using Student’s t-tests or two-way ANOVA 
as appropriate, *p˂0.05.
Figure 6. Palmitate impairs satellite cell differentiation in WT and CD36 deficient 
satellite cells. (A) Immunohistochemistry was performed on isolated satellite cells 
derived from WT or CD36 KO mice, that had been transferred from growth medium 
(GM) to differentiation medium (DM) to induce differentiation (scale bar=200µm). (A-
C) Following expansion in GM, differentiation was quantified after 5 days in DM with 
DMSO (control) or palmitate (PA) and/or SSO (CD36 inhibition). Satellite cells were 
immunostained for Myogenin and nuclei counterstained using DAPI to quantify total 
cell numbers. (B) Quantification of Myogenin+ve nuclei inside myoblasts and myotubes 
as a ratio to total DAPI (Myogenin/DAPI ratio. (C) Fusion Index (%) was assessed by 
Myogenin+ve nuclei inside myotubes divided by total DAPI. Data are represented as 
mean±SD (N=3-4 technical replicates, 3 independent experiments) per group. 
Statistical analysis was performed using two-way ANOVA, *p˂0.05 vs WT.
Figure 7. CD36 deficiency and increased fatty acid availability affect the 
metabolic profile of satellite cells. Respiration rate of isolated satellite cells was 
measured using the Seahorse XFp extracellular flux analyser. (A) Schematic of 
Seahorse Extracellular Flux Analysis set up. (B-C) Proliferating satellite cells from WT 
and CD36 KO mice were cultured in a seahorse extracellular flux cell culture plate. (D-
E) Differentiated satellite cells from WT and CD36 KO mice were cultured in a 
seahorse extracellular flux cell culture plate and treated with SSO and/or palmitate 
before subsequent OCR measurements. In total, 13 OCR measurements were taken. 
Measurements are as follows: 3 basal respiration, 3 after the injection of Oligomycin 































































(Inhibition of ATP synthesis), 5 after the injection of FCCP (Uncoupling of ATP 
synthesis) and 2 after the injection of Antimycin (Inhibition of mitochondrial 
respiration). The x-axis represents measurements taken over a time interval of 2 hours 
and OCR values are represented as a mean of 3 independent measurements, shown 
on the y-axis. OCR values were normalised to total protein content and OCR changes 
are shown as pmol/min/µg total protein. Data are represented as mean±SD (N=3 
independent experiments). Statistical analysis was performed using two-way ANOVA 
or Student’s t-test as appropriate, *p˂0.05 vs. WT, #p˂0.05 vs. WT+PA, bp˂0.05 vs. 
CD36KO.   
Figure 8. CD36-deficiency impairs skeletal muscle regeneration after 
cardiotoxin-induced injury in tibialis anterior. (A-B) Representative images for the 
identification of regenerating fibres (haematoxylin & eosin staining, eMHC 
expression), damaged/dying fibres (IgG expression) and intramuscular macrophages 
(CD68) in muscle sections on day 5- and 10- post CTX injury (20x, scale bar=100µm). 
Quantification of CSA distribution from eMHC+ve stained muscle fibres (D5 and D 10) 
and eMHC+ve fibre number (D10, arrowheads), IgG staining inside the muscle fibres 
and CD68 are shown. Data are represented as mean±SD (N=5 per group). Statistical 
analysis was performed by Student’s t-test or chi square test as appropriate with 
*p˂0.05 and $p<0.05 vs. WT. 
Figure 9. Effect of CD36 deficiency and high-fat diet on lipid accumulation in the 
liver. (A) Liver lipid accumulation was detected by Oil red O staining in cross-sections 
(20x, scale bar=100µm). (B) Quantification of lipid droplet distribution versus size. (C) 
Triacylglycerol (TG) and phospholipid (PL) contents (µmol/g) in the liver were 
quantified by gas chromatography. (D) Relative gene expression in the liver for genes 
involved in fatty acid metabolism and lipid fusion was analysed by qRT-PCR. Data are 































































mean±SD (N=6) per group. Statistical analysis was performed by two-way ANOVA, 
*p˂0.05 vs. WT ND, #p˂0.05 vs. WT HF bp˂0.05 vs. CD36KO ND. Lipid droplet 
distribution was analysed by chi square, $p˂0.01 vs. CD36KO ND, &p˂0.05 vs. WT 
HF.
Acknowledgements
AM was funded by the by the European Union (Grant: FP7-PEOPLE-PCIG14-GA-
2013-631440) and KP was funded by the BBSRC (BB/J016454/1).
The authors declare no conflict of interest.
































































Supplementary Table 1. Overview of the effect of CD36 deficiency on blood lipids 
and glucose




(Febbraio, M. et al. 1999 PMID: 
10383407 Goudriaan et al . 2003 
PMID12923231, Brundert et al. 
2011 PMID3284166)
No difference
(Berger et al. 2019 
PMID31289200)
VLDL/IDL ↑1.4 fold
(Masuda, D. et al. 2008 PMID: 
2666186,
↑3fold
(Masuda, D. et al. 2008 PMID: 
2666186)
LDL No difference
(Masuda, D. et al. 2008 PMID: 
2666186
↑2-fold
(Masuda, D. et al. 2008 PMID: 
2666186)
TGs ↑1.3fold- 2.4fold
(Jeltje R. Goudriaan et al. 2005 
PMID: 16024917, Febbraio, M. et 
al. 1999 PMID: 10383407, Coburn 
et al. 2000 PMID: 10913136, 
Masuda, D. et al. 2008 PMID: 
2666186, Goudriaan et al . 2003 
PMID12923231, Hajri et al 2002 
PMID150975)
↑1.3fold
(Jeltje R. Goudriaan et al. 2005 
PMID: 16024917, Hajri et al 2002 
PMID150975)
FFA ↑1.4- 1.9 fold
(Febbraio, M. et al. 1999 PMID: 
10383407, (Masuda, D. et al. 2008 
PMID: 2666186, Jeltje R. 
Goudriaan et al. 2005 PMID: 
16024917, Goudriaan et al . 2003 
PMID12923231, Hajri et al 2002 
PMID150975
↑1.4-2fold
(Masuda, D. et al. 2008 PMID: 
2666186, Koonen et al. 2010 
PMID2874697, Hajri et al 2002 
PMID150975
Glucose ↓0.5- 0.7fold
Goudriaan et al . 2003 
PMID12923231, Hajri et al 2002 
PMID150975
↓1.8- 1.9 fold
Koonen et al. 2010 
PMID2874697, Hajri et al 2002 
PMID150975
































































Supplementary Figure 1. Tissue weight differences in Wild-type and CD36 
deficient mice. (A) Soleus (Sol), (B) Biceps Brachii (BB), (C) Extensor digitorum 
longus (EDL), (D) Tibialis Anterior (TA), (E) heart and (F) White-Adipose-Tissue (WAT) 
from WT and CD36 KO mice fed a ND or a HF diet. Data are represented as mean±SD 
(N=8 per group). Statistical analysis was performed using two-way ANOVA, *p˂0.05 
vs. WT ND, #p ˂0.05 vs. WT HF, bp˂0.05 vs. CD36 KO ND.
Supplementary Figure 2. CD36 deficiency alters diet induced muscle specific 
adaptations/morphometric changes. (A, E) Representative images of cross-
sections from WT and CD36 KO mice fed a ND or HF diet from EDL and Sol muscle 
stained for myosin heavy chain (Mhc) isoforms. EDL and Sol muscle were examined 
for fibre type composition (B, F), and cross-sectional area (CSA) (C-D, G-H), 
respectively. EDL fibre type expression profile (IIA IIB IIX) and Soleus fibre type 
expression profile (IIA I IIX) shown in percentage [%]. Data are represented as 
mean±SD (N=8) per group). Statistical analysis was performed using two-way ANOVA 
or chi square analysis as appropriate, *p˂0.05 vs WT ND.
Supplementary Figure 3. Attenuated DHE staining in the EDL muscle of CD36 
KO mice. Representative images of DHE staining to assess ROS production in EDL 
transverse sections from WT and CD36 KO mice. Quantification of DHE staining 
intensity. Data are represented as mean±SD (N=6) per group. Statistical analysis was 
performed using Student’s t-Test, *p˂0.05.































































Supplementary Figure 4. Compromised myogenic differentiation in CD36 KO 
skeletal myoblasts versus WT. Immunohistochemistry was performed on isolated 
satellite cells derived from WT or CD36 KO mice. Following expansion in growth 
medium, differentiation was quantified after 4 days in differentiation medium (x10 
magnification, scale bar 100μm). Satellite cell differentiation and myotube formation 
was measured by Desmin, SRF and BEX1 and nuclei were counterstained with DAPI. 
Statistical analysis was performed by Student’s t-test. Differences are *p<0.05.
Supplementary Fig. 5. The effect of high-fat diet and CD36 deficiency on MAPKs 
in skeletal muscle. Phosphorylation levels of various MAPKs were assessed in 
skeletal muscle of WT and CD36 KO mice fed a standard chow diet (normal diet, ND) 
or High-fat (HF) diet for 13 weeks. Results of Phospho-MAPK antibody array (R&D). 
The densitometric analysis was presented as fold change. Fold change was calculated 
as: the ratio of each of the 3 groups to WT ND group (n=6/group). 
Supplementary Figure 6. Palmitate increases DHE levels and compromises 
muscle stem cell differentiation that can be reversed by antioxidants in WT mice, 
but not in CD36 KO. (A) Immunohistochemistry was performed on isolated satellite 
cells derived from WT or CD36 KO mice. Following expansion in growth medium (GM), 
differentiation was quantified after 4 days in differentiation medium (DM) with DMSO 
(control), Palmitate, Palmitate + Ebselen (20μM), or Palmitate + TEMPOL (1mM). 
Satellite cells were immunostained for MHC, DHE and nuclei counterstained using 
DAPI (Magnification x20, scale bar 50μm). (B) Quantification of DHE and MHC 
staining intensity (A.U.). Data are represented as mean±SD (N=6 technical replicates, 































































2 independent experiments) per group. Statistical analysis was performed using two-
way ANOVA, *p˂0.05 vs WT, #p<0.05 vs every other WT group. 
Supplementary Figure 7. Palmitate increases DHE levels and compromises 
muscle stem cell differentiation that is reversible by the antioxidant agent 
ebselen in WT, but not in CD36 KO single fibre cultures. (A) Representative 
images show WT and CD36 KO EDL satellite cell staining for DHE and Myogenin 
counterstained with DAPI on single myofibres after 72 h (72 hours) treated with 
Palmitate (0.3mM) and/or Ebselen (20μM). (B) Quantification of DHE levels and 
Myogenin. Data are represented as mean±SD (N=5 mice per condition, 40 fibres per 
group). Statistical analysis was performed using two-way ANOVA, *p˂0.05 vs. WT 
ND, #p˂0.05 vs. every other WT group.
Supplementary Figure 8. The effect of CD36 deficiency on MyoD and Myogenin 
expression in progenitor cells of injured muscle. Acute injury was induced by 
Cardiotoxin injection into the tibialis anterior muscle of WT and CD36 KO mice and 
specimens were studied 5 days post-injury. Representative images and quantitative 
data for MyoD and Myogenin immunohistochemical staining on transverse sections of 
injured muscles, co-stained with DAPI to visualise nuclei. Representative images (x20 
magnification, scale bar 50μm). Statistical analysis was performed by Student’s t-test. 
n=5 animals per group. Differences are *p<0.05.
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